DR Ralph & Marian Falk Medical Research TR
Private foundation · Dallas, TX · EIN 36-6975534 · reported 2025
38grants reported
$176Kmedian award
$174Klower quartile
$57Ksmallest grant
$8.3Mtotal paid
11states reached
Who they funded
| Recipient and stated purpose | Where | Amount |
|---|---|---|
| Case Western Reserve University IMMUNOTHERAPY FOR B CELL | Cleveland, OH | $355,809 |
| Yale University - School OF Medicine MAKING CANCER CELLS LOOK | New Haven, CT | $348,252 |
| Indiana University PIM2 MODULATOR-MULTIPLE | Bloomington, IN | $340,879 |
| Medical College OF Wisconsin PAIN THERAPY - SENSORY | Milwaukee, WI | $334,583 |
| Thomas Jefferson University PROTACS FOR TARGETING BRCA | Philadelphia, PA | $333,333 |
| Cleveland Clinic Foundation DEVELOPMENT OF NEW DRUG FOR | Cleveland, OH | $331,873 |
| Board Regents OF University OF Wisconsin IMPROVE DIAGNOSIS OF BREAST | Milwaukee, WI | $330,487 |
| Medical College OF Wisconsin NEW DRUGS TO TREAT | Milwaukee, WI | $315,981 |
| Universityof Minnesota T3 THERAPY - HEART FAILURE | Minneapolis, MN | $308,897 |
| University OF Minnesota OPTIMIZED MECHANISM BASED | Minneapolis, MN | $284,681 |
| University OF Chicago METASTIC LUNG CANCER PHASE | Chicago, IL | $268,735 |
| Purdue University ADVANCING MICRO RNAS AS | West Lafayette, IN | $257,044 |
| Northwestern University THERAPY FOR CHRONIC KIDNEY | Evanston, IL | $210,398 |
| University OF Iowa VASCULAR HEALTH TARGETING | Iowa City, IA | $208,319 |
| University OF Minnesota SYSTEMIC BACTEREMIA - HOST | Minneapolis, MN | $203,837 |
| Cleveland Clinic Foundation TREATMENT OF COMPLEX | Cleveland, OH | $186,955 |
| Ohio State University MELANOMA ONSET & RECURRENCE | Columbus, OH | $178,604 |
| University OF Minnesota DEVELOP IL-15 - MALARIA | Minneapolis, MN | $176,327 |
| Shirley Ryan Ability Lab RESTORE DIAPHRAGM - NERVE | Chicago, IL | $175,864 |
| Mayo Clinic CD-19 TARGETED CAR-MSC19 IN | Rochester, MN | $175,575 |
| Regents OF University OF Michigan ANTIBODY CNS DELIVERY AND | Ann Arbor, MI | $175,000 |
| Case Western Reserve University PHARMA STRATEGY TO TREAT | Cleveland, OH | $175,000 |
| Brown University OF Providence REPURPOSING CLOPIDOGREL TO | Providence, RI | $175,000 |
| Washington University STEM CELL DERIVED ISLETS | ST Louis, MO | $175,000 |
| University OF Cincinnati DEVELOP IMPROVED METHOD OF | Cleveland, OH | $175,000 |
| Loyola University OF Chicago INHIBITORS FOR TRIPLE | Chicago, IL | $175,000 |
| Michigan State University DEVELOP NEW ODC INHIBITORS | East Lansing, MI | $175,000 |
| Regents OF University OF Michigan NEURO-CARDIAC MECHANISMS OF | Ann Arbor, MI | $175,000 |
| University OF Minnesota SOUND WAVES ASSESSMENT VIA | Minneapolis, MN | $173,839 |
| Children's Hospital Medical Center AUTOIMMUNE ARTHRITIS | Cincinnati, OH | $173,769 |
| Washington University VAGUS NERVE STIMULATION - | ST Louis, MO | $173,717 |
| Brown University OF Providence GENE THERAPY FOR | Providence, RI | $173,096 |
| Indiana University TRAUMATIC BRAIN INJURY | Bloomington, IN | $169,910 |
| Northwestern University ANTIBODIES TREATMENT OF | Evanston, IL | $168,188 |
| Yale University - School OF Medicine ANTI VB2 ANTIBODY DRUG FOR | New Haven, CT | $161,487 |
| Ohio State University DEVELOP NEW THERAPY FOR | Columbus, OH | $151,908 |
| University OF Minnesota SEVERITY MEASURE- ADDUCTOR | Minneapolis, MN | $150,426 |
| Indiana University INHIBITORS-PEANUT SPECIFIC | Bloomington, IN | $57,018 |
Which foundations would fund your organization?
Tell us what you do, where you are and how big you are. We search 717,948 reported grants and hand back the foundations that already funded organizations like yours, at a size you can actually win.
Get your funder match — $29